
Oscar Health (OSCR) Stock Forecast & Price Target
Oscar Health (OSCR) Analyst Ratings
Bulls say
Oscar Health Inc. demonstrated a strong financial performance in the second quarter of 2025, with revenue reaching $2.86 billion, reflecting a year-over-year increase of 29% driven by robust retention and member growth. The company's medical loss ratio (MLR) improved significantly, coming in at 91.1%, which is 1200 basis points higher than the previous year and indicates effective health management despite increased market-wide morbidity. Additionally, Oscar Health projects substantial growth in enrollment weighted direct policy premiums, forecasting a 28.5% rise for calendar year 2026 and a 16.9% rise for 2027, underscoring a positive outlook for revenue expansion.
Bears say
Oscar Health is facing a challenging outlook due to projected declines in the mix of higher-margin Silver plans from 57.5% in 2026 to 51.0% in 2027, while lower-margin Bronze plans increase significantly, indicating potential revenue pressure. The anticipated expiration of E-APTCs by the end of 2025 could lead to a substantial drop in Individual ACA Marketplace enrollment, estimated between 20% to 30%, resulting in a loss of approximately 6.1 million lives from 2025 to 2026. Additionally, even though the SG&A ratio has improved, the adjusted EBITDA margin remains low at 2.4%, reflecting ongoing challenges in achieving profitability amidst declining enrollment and shifting plan dynamics.
This aggregate rating is based on analysts' research of Oscar Health and is not a guaranteed prediction by Public.com or investment advice.
Oscar Health (OSCR) Analyst Forecast & Price Prediction
Start investing in Oscar Health (OSCR)
Order type
Buy in
Order amount
Est. shares
0 shares